Takashi Satoh

Takashi Satoh has an extensive background in the pharmaceutical industry, with experience as a Principal Scientist at Civetta Therapeutics, X-Chem, Inc., and Eisai. Prior to these roles, they held positions at Celgene, Northeastern University, and H3 Biomedicine, focusing on medicinal chemistry. Takashi Satoh has a proven track record in drug discovery and research, with valuable expertise in the field.